Use: According to the latest findings, the routine screening for antibodies directed against alpha-fodrin can be a useful tool in diagnosing early-stage Sjogren’s syndrome.

Limitations: This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.

Methodology: Enzyme-linked immunosorbent assay (ELISA)